Skip to content

GeneFrontier ジーンフロンティア株式会社

  • Solutions
    • Koutai Shokunin
      • Overview
      • Price
      • Flow
      • Cases
      • Publications
      • FAQ
    • PUREfrex®
      • Overview
      • Lineup
      • Technology
    • PUREfrex® RD
      • Overview
      • Cases
      • Publications
      • FAQ
    • Drug Discovery
      • Overview
  • Support
    • Downloads
      • Koutai Shokunin
      • PUREfrex®
      • PUREfrex® RD
    • Cases
      • Koutai Shokunin
      • PUREfrex®
      • PUREfrex® RD
    • News
      • Exhibition
      • Campaign
      • Others
    • FAQ
      • Koutai Shokunin
      • Purefrex®
      • PUREfrex® RD
  • Company
    • Intoroduction
    • Corporate Profile
    • Access
    • Partners
  • Contact
    • General Contact Form
    • Koutai Shokunin Contact Form
    • PUREfrex® Contact Form
検索 検索
日本語
English

Downloads

  • Home
  • Support
  • Downloads
  • PUREfrex® RD
  • Selection and Affinity Maturation of Cyclic Peptide Against CTLA4 with PUREfrexRD [2019]
  • All
  • Koutai Shokunin
  • PUREfrex®
  • PUREfrex® RD

  • Selection and Affinity Maturation of Cyclic Peptide Against CTLA4 with PUREfrexRD [2019]

    PEGS2019 – the essential protein engineering summit
    <cyclic peptide selection, affinity maturation, CTL4>

    PUREfrex® RD
    Download
  • Solutions
    • Koutai Shokunin
    • PUREfrex®
    • PUREfrex® RD
    • Drug Discovery
  • Support
    • Downloads
    • Cases
    • News
    • FAQ
  • Company
    • Intoroduction
    • Corporate Profile
    • Access
    • Partners
  • Contact
    • General Contact Form
    • Koutai Shokunin Contact Form
    • PUREfrex® Contact Form
  • Recruit
  • Privacy Policy
Copyright © 2025, GeneFrontier Corporation All rights reserved.